Life Sciences Cos. Should Assess Charitable Donations Programs

By Gary Giampetruzzi, Jane Yoon and Jessica Montes (June 20, 2018, 3:27 PM EDT) -- On June 6, 2018, H. Lundbeck A/S announced that its subsidiary, Lundbeck LLC, (referred to as Lundbeck), has reached a $52.6 million agreement-in-principle with the U.S. Attorney's Office for the District of Massachusetts, or USAO-MA, to resolve an investigation into its donations to independent copay assistance charities. This announcement comes over three years after the USAO-MA launched an industry-wide investigation into manufacturer donations to charities providing copay assistance to federal health care program beneficiaries, and this is the fifth company in the last nine months to announce a finalized resolution or agreement-in-principle to resolve an investigation with this office. As reflected by public disclosures, at least nine other pharmaceutical manufacturers and three dialysis service providers remain under investigation. As the list of resolutions grows longer, life sciences companies should assess, or reassess, their policies, procedures and monitoring regarding donations to copay assistance charities....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!